eaa777cd_CER_Inventory___CER_Inventory__Category
[Agency] NIH [Project Title] RESISTANCE TO AORTIC ENDOGRAFT MIGRATION: COMPARATIVE EFFECTIVENESS OF FDA APPROVAL [Institution] STANFORD UNIVERSITY [Amount] $499,991 [Summary] Endovascular repair has become the primary treatment for abdominal aortic aneurysm (AAA) disease. There are currently 5 FDA approved endograft devices for AAA repair. The true in-vivo biomechanical environment experienced by these devices is poorly understood. Furthermore, there are currently no studies that compare the performance of the different devices with regards to their long term positional stability (migration). [Completion/ Closing Date] 09/02/2010 [Link] link [Category] 
Medical treatments, items and services
CER Inventory | CER Inventory
Category